Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis

ABSTRACT Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. By releasing blocks (checkpoints) on the immune system, they elicit powerful antitumor effects. Despite improving survival, ICIs are associated with serious cardiac toxicities. Previous reports have focused...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Asma Dilawari, Mori J. Krantz, Ilynn Bulatao, Hee‐Koung Joeng, Marc Neilson, Suparna Wedam, Xin Gao, Mallorie H. Fiero, Abhilasha Nair, Marc Theoret, Laleh Amiri‐Kordestani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-05-01
Edice:	Annals of Noninvasive Electrocardiology
Témata:	adjuvant cancer cardio oncology cardiotoxicity immune checkpoint inhibitors immunotherapy
On-line přístup:	https://doi.org/10.1111/anec.70087
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!